Portfolio Companies News
August 13, 2019Strongbridge Biopharma Announces Ke...
~ Richard S. Kollender Appointed to Chief Operating Officer ~ ~ Robert Lutz Promoted to Chief Financial Officer ~ ~ David Gill Appointed to Board of Directors ~ DUBLIN, Ireland and TREVOSE, Pa., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: S... read more
August 13, 2019Altimmune Announces Second Quarter ...
Conference Call & Webcast Scheduled for Wednesday, August 14, at 8:30am Eastern Time GAITHERSBURG, Md., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc.(Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the three and six months ended June 30, 2... read more
August 12, 2019Targovax ASA: Announcement of secon...
Oslo, Norway, 12 August 2019 – Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, will announce its second quarter and first half 2019 results on Thursday, 22 August 2019. A presentation by Targovax’s manageme... read more
August 5, 2019Aprea Therapeutics Appoints Scott C...
BOSTON and STOCKHOLM, Aug. 5, 2019 /PRNewswire/ -- Aprea Therapeutics, a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein, today announced the appointment of Scott Coiante as Senior Vice... read more
August 5, 2019Altimmune to Announce Second Quarte...
GAITHERSBURG, Md., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc.(Nasdaq: ALT), a clinical stage biopharmaceutical company focused on developing liver disease and immune modulating therapies, today announced that it will report financial results for the three and six months ended June 30, 201... read more
August 01, 2019Q2 2019 General Market Overview
Since the start in 1996, HealthCap funds have invested in 114 portfolio companies.
42 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.